Fulcrum Therapeutics Enters into a Collaboration and License Agreement with Sanofi for the Development and Commercialization of Losmapimod in Facioscapulohumeral Muscular Dystrophy
Rare Disease Day
At the kind invitation of Dr. Alberto Malerba, Lecturer in Gene...
0 Comments